Perfusion characteristics of moyamoya disease : An anatomically and clinically oriented analysis and comparison

Stroke

Volumn 45, Issue 1, 2014, Pages 101-106

  Schubert, Gerrit Alexander ^a,b   Czabanka, Marcus ^c   Seiz, Marcel ^b   Horn, Peter ^d   Vajkoczy, Peter ^c   Thomé, Claudius ^e  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d DR HORST SCHMIDT KLINIKEN   (Germany)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Computed tomography; Moyamoya disease; Perfusion; Xenon

Indexed keywords

EID: 84893754888     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.003370     Document Type: Article

References (25)

1. Powers WJ, Clarke WR, Grubb RL Jr, Videen TO, Adams HP Jr, Derdeyn CP; COSS Investigators. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA. 2011;306:1983-1992.
2. Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011;42:3304-3310.
3. Czabanka M, Pena-Tapia P, Scharf J, Schubert GA, Münch E, Horn P, et al. Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease. Cerebrovasc Dis. 2011;32:361-369.
4. Czabanka M, Pena-Tapia P, Schubert GA, Woitzik J, Vajkoczy P, Schmiedek P. Characterization of cortical microvascularization in adult moyamoya disease. Stroke. 2008;39:1703-1709.
5. Schmiedek P, Piepgras A, Leinsinger G, Kirsch CM, Einhüpl K. Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. J Neurosurg. 1994;81:236-244.
6. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg. 1993;79:483-489.
7. Gupta A, Chazen JL, Hartman M, Delgado D, Anumula N, Shao H, et al. Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis. Stroke. 2012;43:2884-2891.
8. Czabanka M, Pena-Tapia P, Schubert GA, Heppner FL, Martus P, Horn P, et al. Proposal for a new grading of Moyamoya disease in adult patients. Cerebrovasc Dis. 2011;32:41-50.
9. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288-299.
10. Lee M, Zaharchuk G, Guzman R, Achrol A, Bell-Stephens T, Steinberg GK. Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus. 2009;26:E5.
11. Gur D, Yonas H, Herbert D, Wolfson SK, Kennedy WH, Drayer BP, et al. Xenon enhanced dynamic computed tomography: multilevel cerebral blood flow studies. J Comput Assist Tomogr. 1981;5:334-340.
12. Johnson DW, Stringer WA, Marks MP, Yonas H, Good WF, Gur D. Stable xenon CT cerebral blood flow imaging: rationale for and role in clinical decision making. AJNR Am J Neuroradiol. 1991;12:201-213.
13. Schubert GA, Seiz M, Czabanka M, Thomé C. Perfusion characteristics in chronic cerebrovascular insufficiency: an anatomically and clinically oriented xect analysis of cerebrovascular atherosclerotic disease. Transl Stroke Res. 2011;3:122-129.
14. Schubert GA, Seiz M, Hegewald AA, Manville J, Thomé C. Acute hypoperfusion immediately after subarachnoid hemorrhage: a xenon contrastenhanced CT study. J Neurotrauma. 2009;26:2225-2231.
15. Kashiwagi S, Yamashita T, Katoh S, Kitahara T, Nakashima K, Yasuhara S, et al. Regression of moyamoya vessels and hemodynamic changes after successful revascularization in childhood moyamoya disease. Acta Neurol Scand Suppl. 1996;166:85-88.
16. Suzuki R, Nariai T, Matsushima Y, Hirakawa K. Xe-CT in cerebrovascular disease and moyamoya disease. Acta Neurol Scand Suppl. 1996;166:69-71.
17. Ogawa A, Yoshimoto T, Suzuki J, Sakurai Y. Cerebral blood flow in moyamoya disease. Part 1: Correlation with age and regional distribution. Acta Neurochir (Wien). 1990;105:30-34.
18. Kuwabara Y, Ichiya Y, Otsuka M, Tahara T, Gunasekera R, Hasuo K, et al. Cerebral hemodynamic change in the child and the adult with moyamoya disease. Stroke. 1990;21:272-277.
19. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056-1066.
20. Nogawa S, Fukuuchi Y, Kobari M, Obara K, Watanabe S, Yamaguchi K, et al. Local cerebral hemodynamic changes through the angiographic stages of moyamoya disease. Keio J Med. 2000;49(suppl 1):A90-A94.
21. Horowitz M, Yonas H, Albright AL. Evaluation of cerebral blood flow and hemodynamic reserve in symptomatic moyamoya disease using stable Xenon-CT blood flow. Surg Neurol. 1995;44:251-261, discussion 262.
22. Obara K, Fukuuchi Y, Kobari M, Watanabe S, Dembo T. Cerebral hemodynamics in patients with moyamoya disease and in patients with atherosclerotic occlusion of the major cerebral arterial trunks. Clin Neurol Neurosurg. 1997;99(suppl 2):S86-S89.
23. Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJ, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain. 1990;113(pt 1):27-47.
24. Buijs PC, Krabbe-Hartkamp MJ, Bakker CJ, de Lange EE, Ramos LM, Breteler MM, et al. Effect of age on cerebral blood flow: measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults. Radiology. 1998;209:667-674.
25. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT III, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37:1490-1496.